enow.com Web Search

  1. Ads

    related to: position paper for pulmonary hypertension treatment medications

Search results

  1. Results from the WOW.Com Content Network
  2. Pulmonary arterial hypertension - Wikipedia

    en.wikipedia.org/.../Pulmonary_arterial_hypertension

    A pulmonary artery wedge pressure being less than 15 mmHg (also measured by right heart catheterization) excludes post-capillary bed (in the veins distal to the capillary bed) pulmonary hypertension. Pulmonary arterial hypertension is a subgroup of pulmonary hypertension and is categorized as World Health Organization as group 1. [3]

  3. Pulmonary hypertension - Wikipedia

    en.wikipedia.org/wiki/Pulmonary_hypertension

    Treatment of pulmonary hypertension is determined by whether the PH is arterial, venous, hypoxic, thromboembolic, or miscellaneous. If it is caused by left heart disease, the treatment is to optimize left ventricular function by the use of medication or to repair/replace the mitral valve or aortic valve. [68]

  4. Ambrisentan - Wikipedia

    en.wikipedia.org/wiki/Ambrisentan

    Ambrisentan is a drug that blocks endothelin, an endogenous hormone found in higher quantities in patients with pulmonary arterial hypertension. Endothelin binds to two receptors, ET A and ET B . ET A is responsible for cell growth in the vessels as well as vasoconstriction , while ET B plays a role in vasodilation , endothelin 1 clearance, and ...

  5. Management of hypertension - Wikipedia

    en.wikipedia.org/wiki/Management_of_hypertension

    Several classes of medications, collectively referred to as antihypertensive medications, are available for treating hypertension. Use should take into account the person's cardiovascular risk (including risk of myocardial infarction and stroke), as well as blood pressure readings, in order to gain a more accurate picture of the person's risks.

  6. Endothelin receptor antagonist - Wikipedia

    en.wikipedia.org/wiki/Endothelin_receptor_antagonist

    An endothelin receptor antagonist (ERA) is a drug that blocks endothelin receptors.. Three main kinds of ERAs exist: Dual ET Receptor Antagonists, which affect both endothelin A (ET A) and B receptors (ET B) [1]

  7. Bosentan - Wikipedia

    en.wikipedia.org/wiki/Bosentan

    Bosentan, sold under the brand name Tracleer among others, is a dual endothelin receptor antagonist medication used in the treatment of pulmonary artery hypertension (PAH). [ 4 ] [ 5 ] Bosentan is available as film-coated tablets (62.5 mg or 125 mg) or as dispersable tablets for oral suspension (32 mg).

  1. Ads

    related to: position paper for pulmonary hypertension treatment medications